Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Antimicrobial resistance is an urgent threat to public health and global development; in this
scenario, the SARS-CoV2 pandemic has caused a major disruption of healthcare systems …

Data on the prevalence of bacterial co-infections and secondary infection among adults with
COVID-19 admitted to the intensive care unit (ICU) are rare. We aimed to determine the …

Aim: This study aims to assess the changes in antimicrobial resistance among some critical
and high-priority microorganisms collected previously and during the coronavirus disease …

Abstract Background Bloodstream infections (BSIs) are an emerging cause of significant
morbidity and mortality in severe Coronavirus disease 2019 (COVID-19). We aimed to …

Mucormycosis is a serious and potentially fatal fungal infection caused by a type of rare but
opportunistic fungal pathogen called mucormycetes. Recently, mucormycosis, also known …

Antimicrobial resistance (AMR) is an emerging public health problem in modern times and
the current COVID-19 pandemic has further exaggerated this problem. Due to bacterial co …

Background The novel coronavirus has embarked on a global pandemic and severe
mortality with limited access for its treatments and medications. For the lack of time …

Background: COVID-19 patients are typically prescribed antibiotics empirically despite
concerns. There is a need to evaluate antibiotic use among hospitalized COVID-19 patients …

Changes in hospitals' daily practice due to COVID-19 pandemic may have an impact on
antimicrobial resistance (AMR). We aimed to assess this possible impact as captured by the …